BERLIN (Reuters) – The decision by more than a dozen European countries to suspend AstraZeneca’s COVID-19 shot faced deepening scrutiny on Wednesday, amid concerns the step could undermine public confidence and delay efforts to beat the coronavirus pandemic.
Source: Reuters
